Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks

NCT05711810 is registered in ClinicalTrials.gov with Yang I. Pachankis as lead sponsor.

NCT NCT05711810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05711810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks
Lead sponsor
Yang I. Pachankis
Phase
Phase 4
Overall status
Completed
Start date
January 2, 2023
Completion date
January 12, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection viral, myocarditis allergic, renal dialysis, severe acute respiratory syndrome-related coronavirus, vaccines